Getinge Partnership

We are excited to announce the expansion of our recent partnership with Getinge to promote and distribute their Vascular Interventions portfolio into the New Zealand healthcare market from 1st June 2024.

Encompassing the Advanta V12 covered stents and VXT, Flixene, and Hemagard Synergy vascular grafts, this collaboration will combine InterMed and Getinge’s expertise, resources, and innovative approaches to ensure we offer the very best of both companies.

We look forward to the possibilities this collaboration will bring and its positive impact on patients’ lives.